Bishopp Casey, Mungai-Barris Zoe, Briedenhann Elmari, Donaldson Emily, Irungu Elizabeth, Schwartz Katie
Family Health International 360, Durham, NC, USA.
Mann Global Health, Columbus, NC, USA.
Curr HIV/AIDS Rep. 2024 Dec 7;22(1):7. doi: 10.1007/s11904-024-00715-y.
As injectable cabotegravir for pre-exposure prophylaxis (CAB PrEP) is introduced in sub-Saharan Africa, it is important to understand how behavioral drivers may influence women's decisions around whether or not to use it.
Facilitating factors include prior familiarity with injections and the perceived efficacy of CAB PrEP, while barriers include a fear or dislike of needles and negative attitudes held by community members and influencers. Further research is needed to fully understand behavioral factors affecting African women's CAB PrEP use. HIV prevention policymakers, practitioners, advocates, and clients are optimistic about CAB PrEP, predicting that this long-acting method will be popular among women in sub-Saharan Africa. However, women may also face barriers to use. Knowledge of behavioral facilitators and barriers can enhance the adaptation or development of HIV prevention communication and demand generation strategies that support informed decision-making in a multi-method market.
随着用于暴露前预防的注射用卡博特韦（CAB PrEP）在撒哈拉以南非洲地区的引入，了解行为驱动因素如何影响女性关于是否使用它的决策非常重要。
促进因素包括先前对注射的熟悉程度以及对CAB PrEP疗效的认知，而障碍包括对针头的恐惧或厌恶以及社区成员和有影响力的人持有的负面态度。需要进一步研究以充分了解影响非洲女性使用CAB PrEP的行为因素。艾滋病毒预防政策制定者、从业者、倡导者和服务对象对CAB PrEP持乐观态度，预测这种长效方法将在撒哈拉以南非洲地区的女性中受到欢迎。然而，女性在使用方面也可能面临障碍。了解行为促进因素和障碍可以加强艾滋病毒预防沟通及需求生成策略的调整或制定，这些策略支持在多方法市场中做出明智决策。
